Results Of An Extended Depth Of Focus Intraocular Lens Implantation In The Second Eye Of Monofocal Pseudophakic Patients
Published 2023 - 41st Congress of the ESCRS
Reference: PP10.04 | DOI: 10.82333/fq0b-0m66
Authors: Rachel Shemesh 1 , Olga Reitblat 2 , Luba Rodov 3 , Adi Levi 4 , Ehud I. Assia 4 , Guy Kleinmann* 5
13. Sheba Medical centerl,Tel-Aviv,Israel, 24. Department of Ophthalmolog,Rabin Medical Center,Petach Tikva,Israel, 35. Kaplan Medical Center,Petach Tikva,Israel, 4Ein-Tal,Tel-Aviv,Israel, 5E. Wolfson Medical Center,Tel-Aviv,Israel
To investigate the visual results and patient satisfaction after implantation of an extended depth-of-focus intraocular lens (EDOF IOL) in the second eye of patients implanted previously with a monofocal IOL in the first eye.
A retrospective study
The medical records and self-reported questionnaires from patients who were implanted with monofocal IOLs in the first eye and EDOF IOLs in the second eye (group A) and patients implanted bilaterally with EDOF IOLs (group B) were compared for visual acuity (VA), spectacle independence, patient satisfaction, and photic phenomena.
Group A (23 eyes of 23 patients) had similar distance uncorrected VA and intermediate uncorrected VA compared with group B (72 eyes of 36 patients), (0.03±0.05 vs 0.04±0.16; p =0.136, and p =0.660 respectively). There was a tendency towards a better near uncorrected VA in group A compared to group B (0.15±0.14 vs 0.23±0.17; p =0.074). Patients' perception of their VA was similar between groups. Spectacle independence for distance vision was reported by 16/17 (94.1%) and 35/36 (97.2%) patients, p= 0.543, 13/17 (76.5%) and 32/36 (88.9%) patients, p= 0.252, for intermediate vision, and 4/17 (23.6%) and 22/36 (61.1%) patients for near vision, p= 0.011, in groups A and B, respectively. No difference in complaints of photic phenomena was noted.
Patients, previously implanted with a monofocal IOL in one eye who are interested in improving their spectacle independence can be considered for an EDOF IOL implantation in the second eye and can expect similar results to those implanted bilaterally with EDOF IOLs.